To investigate whether simultaneous inhibition of FGFR4 and CB1 receptors causes a greater anti-obesity effect, DIO mice were treated with FGFR4 ASO, control ASO or saline for 8 weeks. The gene discussed is FGFR4; the disease is obesity due to melanocortin 4 receptor deficiency.